{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:31:14Z","timestamp":1789950674399,"version":"4.0.1"},"reference-count":51,"publisher":"Japanese Association for Laboratory Animal Science","issue":"4","funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"crossref","award":["19181MFDS481"],"award-info":[{"award-number":["19181MFDS481"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"crossref","award":["24211MFDS257"],"award-info":[{"award-number":["24211MFDS257"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1538\/expanim.24-0100","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:07:52Z","timestamp":1747246072000},"page":"440-451","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of the characteristics of non-alcoholic fatty liver disease in C57BL\/6J-&lt;i&gt;Lepr&lt;sup&gt;em1hwl&lt;\/sup&gt;&lt;\/i&gt;\/Korl and C57BLKS\/J-&lt;i&gt;Lepr&lt;sup&gt;db&lt;\/sup&gt;&lt;\/i&gt;\/J mice"],"prefix":"10.1538","volume":"74","author":[{"given":"Seungwoo","family":"Lee","sequence":"first","affiliation":[{"name":"Nonclinical Resources Research Division, National Institute of Food and              Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong Health Technology              Administration Complex, 187, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do              28159, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hong","family":"Min","sequence":"additional","affiliation":[{"name":"Nonclinical Resources Research Division, National Institute of Food and              Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong Health Technology              Administration Complex, 187, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do              28159, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Jun","family":"Kim","sequence":"additional","affiliation":[{"name":"Blood Products Division, National Institute of Food and Drug Safety              Evaluation, Ministry of Food and Drug Safety, Osong Health Technology Administration              Complex, 187, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28159, Republic              of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somi","family":"Yun","sequence":"additional","affiliation":[{"name":"Cosmetics Evaluation Division, National Institute of Food and Drug Safety              Evaluation, Ministry of Food and Drug Safety, Osong Health Technology Administration              Complex, 187, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28159, Republic              of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Kyoung","family":"Seo","sequence":"additional","affiliation":[{"name":"Nonclinical Resources Research Division, National Institute of Food and              Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong Health Technology              Administration Complex, 187, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do              28159, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Kwon","family":"Lee","sequence":"additional","affiliation":[{"name":"Nonclinical Resources Research Division, National Institute of Food and              Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong Health Technology              Administration Complex, 187, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do              28159, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Huang              L, Li              C. Leptin: a            multifunctional hormone. Cell Res. 2000;            10: 81\u201392.","DOI":"10.1038\/sj.cr.7290038"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gorska              E, Popko              K,                Stelmaszczyk-Emmel              A, Ciepiela              O, Kucharska              A, Wasik              M. Leptin            receptors. Eur J Med Res. 2010;            15:(Suppl 2):            50\u201354.","DOI":"10.1186\/2047-783X-15-S2-50"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Savova              MS, Mihaylova              LV, Tews              D, Wabitsch              M, Georgiev              MI. Targeting            PI3K\/AKT signaling pathway in obesity. Biomed            Pharmacother. 2023; 159: 114244.","DOI":"10.1016\/j.biopha.2023.114244"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Chua              SC              Jr, White              DW, Wu-Peng              XS, Liu              SM, Okada              N, Kershaw              EE, et            al.  Phenotype of fatty due to Gln269Pro mutation in            the leptin receptor (Lepr). Diabetes.          1996; 45: 1141\u20131143.","DOI":"10.2337\/diab.45.8.1141"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Belouzard              S, Delcroix              D, Rouill\u00e9              Y. Low levels            of expression of leptin receptor at the cell surface result from constitutive            endocytosis and intracellular retention in the biosynthetic pathway.            J Biol Chem. 2004; 279:            28499\u201328508.","DOI":"10.1074\/jbc.M400508200"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Piattini              F, Le Foll              C, Kisielow              J, Rosenwald              E, Nielsen              P, Lutz              T, et            al.  A spontaneous leptin receptor point mutation            causes obesity and differentially affects leptin signaling in hypothalamic nuclei            resulting in metabolic dysfunctions distinct from db\/db mice.            Mol Metab. 2019; 25:            131\u2013141.","DOI":"10.1016\/j.molmet.2019.04.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Berger              C, Heyne              HO, Heiland              T, Dommel              S, H\u00f6fling              C,                Guiu-Jurado              E, et            al.  A novel compound heterozygous leptin receptor            mutation causes more severe obesity than in Lepr<sup>db\/db<\/sup> mice.            J Lipid Res. 2021; 62:            100105.","DOI":"10.1016\/j.jlr.2021.100105"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Roh              JI, Lee              J, Park              SU, Kang              YS, Lee              J, Oh              AR, et            al.  CRISPR-Cas9-mediated generation of obese and            diabetic mouse models. Exp Anim. 2018;            67: 229\u2013237.","DOI":"10.1538\/expanim.17-0123"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Chen              H, Charlat              O, Tartaglia              LA, Woolf              EA, Weng              X, Ellis              SJ, et            al.  Evidence that the diabetes gene encodes the            leptin receptor: identification of a mutation in the leptin receptor gene in db\/db            mice. Cell. 1996; 84:            491\u2013495.","DOI":"10.1016\/S0092-8674(00)81294-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wang              B,                Chandrasekera              PC, Pippin              JJ. Leptin- and            leptin receptor-deficient rodent models: relevance for human type 2            diabetes. Curr Diabetes Rev. 2014;            10: 131\u2013145.","DOI":"10.2174\/1573399810666140508121012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Han              SK, Baik              SK, Kim              MY.            Non-alcoholic fatty liver disease: Definition and            subtypes. Clin Mol Hepatol. 2023;            29:(suppl):            S5\u2013S16.","DOI":"10.3350\/cmh.2022.0424"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Softic              S, Cohen              DE, Kahn              CR. Role of            dietary fructose and hepatic de novo lipogenesis in fatty liver disease.            Dig Dis Sci. 2016; 61:            1282\u20131293.","DOI":"10.1007\/s10620-016-4054-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ortiz              C,                Schierwagen              R, Schaefer              L, Klein              S, Trepat              X, Trebicka              J.            Extracellular matrix remodeling in chronic liver disease.            Curr Tissue Microenviron Rep. 2021; 2:            41\u201352.","DOI":"10.1007\/s43152-021-00030-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wang              Z, Du              K, Jin              N, Tang              B, Zhang              W. Macrophage            in liver Fibrosis: Identities and mechanisms. Int            Immunopharmacol. 2023; 120:          110357.","DOI":"10.1016\/j.intimp.2023.110357"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nishad              A, Naseem              A, Rani              S, Malik              S. Automated            qualitative batch measurement of lipid droplets in the liver of bird using            ImageJ. STAR Protoc. 2023;            4: 102466.","DOI":"10.1016\/j.xpro.2023.102466"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Kleiner              DE, Brunt              EM, Van Natta              M, Behling              C, Contos              MJ, Cummings              OW, et            al.   Nonalcoholic Steatohepatitis Clinical Research            Network. Design and validation of a histological scoring            system for nonalcoholic fatty liver disease.          Hepatology. 2005; 41:            1313\u20131321.","DOI":"10.1002\/hep.20701"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lee              S, Nam              KH, Seong              JK, Ryu              DY. Molybdate            attenuates lipid accumulation in the livers of mice fed a diet deficient in methionine            and choline. Biol Pharm Bull. 2018;            41: 1203\u20131210.","DOI":"10.1248\/bpb.b18-00020"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Lee              S, Kim              S, Hwang              S,                Cherrington              NJ, Ryu              DY.            Dysregulated expression of proteins associated with ER stress, autophagy            and apoptosis in tissues from nonalcoholic fatty liver disease.            Oncotarget. 2017; 8:            63370\u201363381.","DOI":"10.18632\/oncotarget.18812"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jahn              D, Kircher              S, Hermanns              HM, Geier              A. Animal            models of NAFLD from a hepatologist\u2019s point of view. Biochim            Biophys Acta Mol Basis Dis. 2019; 1865:            943\u2013953.","DOI":"10.1016\/j.bbadis.2018.06.023"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kim              KE, Jung              Y, Min              S, Nam              M, Heo              RW, Jeon              BT, et            al.  Caloric restriction of db\/db mice reverts            hepatic steatosis and body weight with divergent hepatic metabolism.            Sci Rep. 2016; 6: 30111.","DOI":"10.1038\/srep30111"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zhai              M, Yan              X, Liu              J, Long              Z, Zhao              S, Li              W, et            al.  Electromagnetic fields ameliorate insulin            resistance and hepatic steatosis by modulating redox homeostasis and SREBP-1c expression            in db\/db mice. Diabetes Metab Syndr Obes.            2021; 14: 1035\u20131042.","DOI":"10.2147\/DMSO.S294020"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Horakova              O, Sistilli              G, Kalendova              V, Bardova              K, Mitrovic              M, Cajka              T, et            al.  Thermoneutral housing promotes hepatic steatosis            in standard diet-fed C57BL\/6N mice, with a less pronounced effect on NAFLD progression            upon high-fat feeding. Front Endocrinol (Lausanne).            2023; 14: 1205703.","DOI":"10.3389\/fendo.2023.1205703"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Davis              RC,                Castellani              LW, Hosseini              M, Ben-Zeev              O, Mao              HZ, Weinstein              MM, et            al.  Early hepatic insulin resistance precedes the            onset of diabetes in obese C57BLKS-db\/db mice.          Diabetes. 2010; 59:            1616\u20131625.","DOI":"10.2337\/db09-0878"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kawashita              E, Ishihara              K, Nomoto              M, Taniguchi              M, Akiba              S. A            comparative analysis of hepatic pathological phenotypes in C57BL\/6J and C57BL\/6N mouse            strains in non-alcoholic steatohepatitis models. Sci            Rep. 2019; 9: 204.","DOI":"10.1038\/s41598-018-36862-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Karimkhanloo              H, Keenan              SN, Bayliss              J, De Nardo              W, Miotto              PM, Devereux              CJ, et            al.  Mouse strain-dependent variation in metabolic            associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical            studies. Sci Rep. 2023;            13: 4711.","DOI":"10.1038\/s41598-023-32037-1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Benegiamo              G, von                Alvensleben              GVG,                Rodr\u00edguez-L\u00f3pez              S, Goeminne              LJE, Bachmann              AM, Morel              JD, et            al.  The genetic background shapes the susceptibility            to mitochondrial dysfunction and NASH progression. J Exp            Med. 2023; 220: e20221738.","DOI":"10.1084\/jem.20221738"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Swellam              M, Hamdy              N. Association            of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene            encoding leptin receptor. IUBMB Life.          2012; 64: 180\u2013186.","DOI":"10.1002\/iub.597"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Zain              SM, Mohamed              Z, Mahadeva              S, Cheah              PL, Rampal              S, Chin              KF, et            al.  Impact of leptin receptor gene variants on risk            of non-alcoholic fatty liver disease and its interaction with adiponutrin            gene. J Gastroenterol Hepatol. 2013;            28: 873\u2013879.","DOI":"10.1111\/jgh.12104"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Osborn              O,                Sanchez-Alavez              M, Brownell              SE, Ross              B, Klaus              J, Dubins              J, et            al.  Metabolic characterization of a mouse deficient            in all known leptin receptor isoforms. Cell Mol            Neurobiol. 2010; 30:            23\u201333.","DOI":"10.1007\/s10571-009-9427-x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Robertson              S,                Ishida-Takahashi              R, Tawara              I, Hu              J, Patterson              CM, Jones              JC, et            al.  Insufficiency of Janus kinase 2-autonomous            leptin receptor signals for most physiologic leptin actions.            Diabetes. 2010; 59:            782\u2013790.","DOI":"10.2337\/db09-1556"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Frederich              RC, Hamann              A, Anderson              S, L\u00f6llmann              B, Lowell              BB, Flier              JS. Leptin            levels reflect body lipid content in mice: evidence for diet-induced resistance to            leptin action. Nat Med. 1995;            1: 1311\u20131314.","DOI":"10.1038\/nm1295-1311"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Knight              ZA, Hannan              KS, Greenberg              ML, Friedman              JM.            Hyperleptinemia is required for the development of leptin            resistance. PLoS One. 2010;            5: e11376.","DOI":"10.1371\/journal.pone.0011376"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Ando              A, Yatagai              T, Rokkaku              K, Nagasaka              S, Ishikawa              SE, Ishibashi              S. Obesity is a            critical risk factor for worsening of glucose tolerance in a family with the mutant            insulin receptor. Diabetes Care. 2002;            25: 1484\u20131485.","DOI":"10.2337\/diacare.25.8.1484"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. K\u00f6nner              AC, Br\u00fcning              JC. Selective            insulin and leptin resistance in metabolic disorders. Cell            Metab. 2012; 16:            144\u2013152.","DOI":"10.1016\/j.cmet.2012.07.004"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Fu              W, Ma              Y, Li              L, Liu              J, Fu              L, Guo              Y, et            al.  Artemether regulates metaflammation to improve            glycolipid metabolism in db\/db mice. Diabetes Metab Syndr            Obes. 2020; 13:            1703\u20131713.","DOI":"10.2147\/DMSO.S240786"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Zahid              S, Dafre              AL, Currais              A, Yu              J, Schubert              D, Maher              P. The            geroprotective drug candidate CMS121 alleviates diabetes, liver inflammation, and renal            damage in db\/db leptin receptor deficient mice. Int J Mol            Sci. 2023; 24: 6828.","DOI":"10.3390\/ijms24076828"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Cohen              P, Zhao              C, Cai              X, Montez              JM, Rohani              SC, Feinstein              P, et            al.  Selective deletion of leptin receptor in neurons            leads to obesity. J Clin Invest. 2001;            108: 1113\u20131121.","DOI":"10.1172\/JCI200113914"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Hackl              MT, F\u00fcrnsinn              C, Schuh              CM, Krssak              M, Carli              F, Guerra              S, et            al.  Brain leptin reduces liver lipids by increasing            hepatic triglyceride secretion and lowering lipogenesis. Nat            Commun. 2019; 10: 2717.","DOI":"10.1038\/s41467-019-10684-1"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Guo              K, McMinn              JE, Ludwig              T, Yu              YH, Yang              G, Chen              L, et            al.  Disruption of peripheral leptin signaling in            mice results in hyperleptinemia without associated metabolic            abnormalities. Endocrinology. 2007;            148: 3987\u20133997.","DOI":"10.1210\/en.2007-0261"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Huang              W, Dedousis              N, Bandi              A, Lopaschuk              GD, O\u2019Doherty              RM. Liver            triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in            vivo. Endocrinology. 2006;            147: 1480\u20131487.","DOI":"10.1210\/en.2005-0731"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Huynh              FK, Levi              J, Denroche              HC, Gray              SL, Voshol              PJ, Neumann              UH, et            al.  Disruption of hepatic leptin signaling protects            mice from age- and diet-related glucose intolerance.            Diabetes. 2010; 59:            3032\u20133040.","DOI":"10.2337\/db10-0074"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Huynh              FK, Neumann              UH, Wang              Y, Rodrigues              B, Kieffer              TJ, Covey              SD. A role for            hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein            composition and liver lipase activity in mice.            Hepatology. 2013; 57:            543\u2013554.","DOI":"10.1002\/hep.26043"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Marsillach              J, Bertran              N, Camps              J, Ferr\u00e9              N, Riu              F, Tous              M, et            al.  The role of circulating monocyte chemoattractant            protein-1 as a marker of hepatic inflammation in patients with chronic liver            disease. Clin Biochem. 2005;            38: 1138\u20131140.","DOI":"10.1016\/j.clinbiochem.2005.09.006"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Yilmaz              Y, Eren              F. Serum            biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic            fatty liver disease: association with liver histology. Eur J            Gastroenterol Hepatol. 2019; 31:            43\u201346.","DOI":"10.1097\/MEG.0000000000001240"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Mauer              J, Denson              JL, Br\u00fcning              JC. Versatile            functions for IL-6 in metabolism and cancer. Trends            Immunol. 2015; 36:            92\u2013101.","DOI":"10.1016\/j.it.2014.12.008"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Sakai              M, Troutman              TD, Seidman              JS, Ouyang              Z, Spann              NJ, Abe              Y, et            al.  Liver-derived signals sequentially reprogram            myeloid enhancers to initiate and maintain Kupffer cell identity.            Immunity. 2019; 51:            655\u2013670.e8.","DOI":"10.1016\/j.immuni.2019.09.002"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Nieto              N.            Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected]            Kupffer cells on stellate cells. Hepatology.            2006; 44: 1487\u20131501.","DOI":"10.1002\/hep.21427"},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. Lis-L\u00f3pez              L, Bauset              C,                Seco-Cervera              M,                Cos\u00edn-Roger              J. Is the            macrophage phenotype determinant for fibrosis            development? Biomedicines. 2021;            9: 1747.","DOI":"10.3390\/biomedicines9121747"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Alkhouli              N, Mansfield              J, Green              E, Bell              J, Knight              B, Liversedge              N, et            al.  The mechanical properties of human adipose            tissues and their relationships to the structure and composition of the extracellular            matrix. Am J Physiol Endocrinol Metab.            2013; 305: E1427\u2013E1435.","DOI":"10.1152\/ajpendo.00111.2013"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Anderson              AA, Helmering              J, Juan              T, Li              CM, McCormick              J, Graham              M, et            al.  Pancreatic islet expression profiling in            diabetes-prone C57BLKS\/J mice reveals transcriptional differences contributed by DBA            loci, including Plagl1 and Nnt. PathoGenetics.            2009; 2: 1.","DOI":"10.1186\/1755-8417-2-1"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Lau              JKC, Zhang              X, Yu              J. Animal            models of non-alcoholic fatty liver disease: current perspectives and recent            advances. J Pathol. 2017;            241: 36\u201344.","DOI":"10.1002\/path.4829"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/74\/4\/74_24-0100\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T04:20:35Z","timestamp":1760156435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/74\/4\/74_24-0100\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.24-0100","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24-0100"}}